All studied parameters were associated with GC clinical stages, as their relative median values upregulated with stages (II, III, IV) except SMAD7 was associated with stage IV only and GHRL did not associate with tumor stages (Table 4, Fig. 1). This evidence concerns the gene GHRL and neoplasm.